GLG Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$79K Buy
+486
New +$87.2K ﹤0.01% 425
2016
Q4
Sell
-9,488
Closed -$2.19M 492
2016
Q3
$2.19M Buy
9,488
+50
+0.5% +$12.2K 0.07% 282
2016
Q2
$2.18M Sell
9,438
-204
-2% -$47K 0.07% 283
2016
Q1
$2.58M Sell
9,642
-76,605
-89% -$21.9M 0.07% 243
2015
Q4
$27M Sell
86,247
-55,915
-39% -$16.6M 0.86% 28
2015
Q3
$38.6M Sell
142,162
-22,363
-14% -$6.87M 1.02% 15
2015
Q2
$49.9M Sell
164,525
-102,378
-38% -$30.5M 1.29% 9
2015
Q1
$79.4M Sell
266,903
-21,894
-8% -$6.24M 2.65% 1
2014
Q4
$74.3M Sell
288,797
-116,516
-29% -$29.1M 2.17% 3
2014
Q3
$97.8M Sell
405,313
-64,575
-14% -$14.5M 2.24% 4
2014
Q2
$105M Sell
469,888
-67,945
-13% -$14.1M 2.5% 2
2014
Q1
$111M Buy
+537,833
New +$107M 2.17% 4
2013
Q3
Sell
-29,021
Closed -$3.66M 275
2013
Q2
$3.66M Buy
+29,021
New +$3.29M 0.14% 145

Other funds holding AGN

GLG Partners's AGN Position: Q4 2017 in Review

GLG Partners opened a new position in Allergan plc (AGN) in Q4 2017: 486 shares worth $79K. The stake represents ﹤0.01% of the portfolio and ranks #425 among its holdings. This is a return to the name: GLG Partners previously reported a position in AGN as recently as Q3 2016.

GLG Partners first reported a position in AGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $111M in Q1 2014. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • GLG Partners held 486 shares of Allergan plc worth $79K as of Q4 2017.
  • Allergan plc was a new GLG Partners position in Q4 2017.
  • Allergan plc made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #425 holding.
  • GLG Partners first reported a position in Allergan plc in Q2 2013 and has held it in 13 quarters since.
  • GLG Partners's Allergan plc position peaked at $111M in Q1 2014.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.